bioAffinity Tech Gains Patent for Lung Disease Detection Platform
Australian patent strengthens global patent portfolio bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing early-stage diagnostics including CyPath® Lung, the Company’s noninvasive test for lung cancer, today...
